Logo
x

Search

Subscribe Now

adhd

ADHD Treatment Options: Therapy, Medication, and More

ADHD Treatment Options: Therapy, Medication, and More

  • May 16, 2024
Supernus' Qelbree (SPN-812) Receives the US FDA's Approval for the Treatment of ADHD

Supernus' Qelbree (SPN-812) Receives the US FDA's Approval for the Treatment of ADHD

  • April 2, 2021
Corium's Azstarys (serdexmethylphenidate and dexmethylphenidate) Receives the US FDA's Approval for ADHD in Patients Aged 6 Years and Older

Corium's Azstarys (serdexmethylphenidate and dexmethylphenidate) Receives the US FDA's Approval for ADHD in Patients Aged 6 Years...

  • March 3, 2021
Akili's EndeavorRx Receives the US FDA's Approval as the First Game-Based Digital Therapeutic to Improve Attention Function in Children with ADHD

Akili's EndeavorRx Receives the US FDA's Approval as the First Game-Based Digital Therapeutic to Improve Attention Function in Chi...

  • June 16, 2020
Shionogi Signs Development & Commercialization Agreement with Akili for its AKL-T01 and AKL-T02 for ADHD & ASD

Shionogi Signs Development & Commercialization Agreement with Akili for its AKL-T01 and AKL-T02 for ADHD & ASD

  • March 8, 2019
Eurofarma Signs an Exclusive Development and Commercialization Agreement with NLS-1 Pharma for its Nalazol Therapy

Eurofarma Signs an Exclusive Development and Commercialization Agreement with NLS-1 Pharma for its Nalazol Therapy

  • February 22, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.